For citations:
Zelberg M.A., Mironov N.Yu., Maykov E.B., Novikov P.S., Yurichev Yu.A., Mironova N.A., Sokolov S.F., Golitsyn S.P. Clinical experience of new antiarrhythmic drug refralon for pharmacological cardioversion in patients with atrial fibrillation after pulmonary vein cryoablation. Journal of Arrhythmology. 2021;28(3):55-62. (In Russ.) https://doi.org/10.35336/VA-2021-3-55-62
Email this article 